HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gene transfer of human prostacyclin synthase into the liver is effective for the treatment of pulmonary hypertension in rats.

AbstractBACKGROUND:
As one of the future strategies of advanced pulmonary hypertension, intrinsic prostacyclin drug delivery using gene therapy may be useful. We investigated whether transfer of the prostacyclin synthase gene into the liver could ameliorate monocrotaline-induced pulmonary hypertension in rats.
METHODS:
The human prostacyclin synthase gene was transfected into the liver of rats with monocrotaline-induced pulmonary hypertension. Hemodynamic indices, blood samples, lung tissues, and survival curves were evaluated between rats receiving the gene and control rats.
RESULTS:
High levels of prostacyclin synthase gene expression were found in the hepatocytes of the prostacyclin synthase group. The level of 6-keto-prostaglandin F(1alpha) was significantly higher in the prostacyclin synthase group (prostacyclin synthase, 35.4 +/- 4.4 ng/mL; control, 22.3 +/- 3.3 ng/mL; P =.0436). The right ventricular/femoral artery pressure ratio was significantly lower in the prostacyclin synthase group than in the control group (prostacyclin synthase, 0.60 +/- 0.039; control, 0.88 +/- 0.051; P =.0036). The endothelin-1 levels in the lung tissues were significantly lower in the prostacyclin synthase group than in the control group (prostacyclin synthase, 10.42 +/- 2.01 pg/mg protein; control, 19.94 +/- 2.82 pg/mg protein; P =.0176). The survival ratio was significantly higher in the prostacyclin synthase group than the control group (P =.0375).
CONCLUSION:
This drug delivery system using gene transfer can be considered as an alternative for continuous intravenous prostacyclin infusion for pulmonary hypertension.
AuthorsHitoshi Suhara, Yoshiki Sawa, Norihide Fukushima, Koji Kagisaki, Chieko Yokoyama, Tadashi Tanabe, Shigeaki Ohtake, Hikaru Matsuda
JournalThe Journal of thoracic and cardiovascular surgery (J Thorac Cardiovasc Surg) Vol. 123 Issue 5 Pg. 855-61 (May 2002) ISSN: 0022-5223 [Print] United States
PMID12019369 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Cytochrome P-450 Enzyme System
  • Intramolecular Oxidoreductases
  • prostacyclin synthetase
Topics
  • Animals
  • Blotting, Western
  • Cytochrome P-450 Enzyme System (genetics, pharmacology)
  • Disease Models, Animal
  • Enzyme-Linked Immunosorbent Assay
  • Gene Transfer Techniques
  • Genetic Therapy (methods)
  • Hypertension, Pulmonary (mortality, therapy)
  • Immunohistochemistry
  • Intramolecular Oxidoreductases (genetics, pharmacology)
  • Liver (drug effects)
  • Lung (drug effects, pathology)
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Reference Values
  • Statistics, Nonparametric
  • Survival Rate
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: